comprehensive -WSS

comprehensive

author：explore 2025-08-23 08:56:51 - browse：1

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Buoyed by wins on obesity, Novo Nordisk eyes heart disease

entertainment

WSS

Weight loss drug costs may need more research, senator suggests

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Measles policy set amid Florida outbreak alarms vaccine proponents

MD Anderson's Padmanee Sharma responds to research credit suit

CRISPR pioneers react to Casgevy, first gene

Opioid cravings were reduced by anti

entertainment

comprehensive

hotspot

How one medical school became remarkably diverse

U.K. considers world's first use of meningitis vaccine to address gonorrhea

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ukraine seeks to reclaim its role as a hub for clinical trials

Activists slam private health insurers over coverage restrictions

Wegovy, Zepbound and weight loss drugs that preserve muscle

Wildfire smoke exposes gaps in outdoor worker protections

As AI regulations shape up, health tech startups beg for clarity

focus

Astellas still sees hope in its gene therapy after four deaths

New CMS data security rules will hurt Medicare, Medicaid research

FDA's Woodcock to retire early next year

Gain of function research would be limited under House proposal

Abridge raises $150m as clinical notes automation market heats up

Medicare Advantage enrollment grows 7.1% to 33.4 million people

hotspot

entertainment

focus

knowledge